alfentanil has been researched along with Chemical Dependence in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Bisch, M; Gambier, N; Gibaja, V; Javot, L; Jouzeau, JY; Jung, J; Kolodziej, A; Pape, E; Scala-Bertola, J | 1 |
Palmquist, KB; Swortwood, MJ | 1 |
Carson, JR; Codd, EE; Colburn, RW; Dax, SL; Flores, CM; Gallantine, EL; Meert, TF; Molino, L; Pullan, S; Razler, CM; Stone, DJ; Van Besien, CR; Wade, PR; Zhang, SP | 1 |
Greenwald, MK; June, HL; Marco, AP; Stitzer, ML | 1 |
1 trial(s) available for alfentanil and Chemical Dependence
Article | Year |
---|---|
Comparative clinical pharmacology of short-acting mu opioids in drug abusers.
Topics: Adolescent; Adult; Alfentanil; Dose-Response Relationship, Drug; Female; Fentanyl; Humans; Male; Middle Aged; Pupil; Receptors, Opioid, mu; Respiration; Substance-Related Disorders | 1996 |
3 other study(ies) available for alfentanil and Chemical Dependence
Article | Year |
---|---|
Multiplex detection of 14 fentanyl analogues and U-47700 in biological samples: Application to a panel of French hospitalized patients.
Topics: Adolescent; Adult; Aged; Alfentanil; Analgesics, Opioid; Benzamides; Child; Child, Preschool; Chromatography, Liquid; Female; Fentanyl; France; Furans; Humans; Infant; Infant, Newborn; Limit of Detection; Male; Middle Aged; Neonatal Abstinence Syndrome; Piperidines; Remifentanil; Retrospective Studies; Substance Abuse Detection; Substance-Related Disorders; Sufentanil; Tandem Mass Spectrometry; Young Adult | 2020 |
Data-independent screening method for 14 fentanyl analogs in whole blood and oral fluid using LC-QTOF-MS.
Topics: Alfentanil; Chromatography, Liquid; Fentanyl; Forensic Toxicology; Furans; Humans; Illicit Drugs; Limit of Detection; Mass Spectrometry; Remifentanil; Saliva; Solid Phase Extraction; Substance Abuse Detection; Substance-Related Disorders; Sufentanil | 2019 |
JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic toler
Topics: Alfentanil; Analgesics, Opioid; Animals; Azabicyclo Compounds; Cricetinae; Drug Tolerance; Gastrointestinal Motility; Guanosine 5'-O-(3-Thiotriphosphate); Hot Temperature; Hyperalgesia; Irritants; Male; Mice; Pain Measurement; Rats; Rats, Wistar; Receptors, Opioid, delta; Respiratory Insufficiency; Seizures; Self Administration; Stomach Ulcer; Substance Withdrawal Syndrome; Substance-Related Disorders; Xanthenes; Zymosan | 2009 |